1st Quarter - Report

ACG ADVOCACY for ROIVANT SCIENCES, INC.

Period 1st Quarter 2018 Filed Apr 20, 2018 Signed by David J. Urban

Official filing
Firm
ACG ADVOCACY
Client
ROIVANT SCIENCES, INC.
Income
$80,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Drug Pricing. Innovation Issues.

LobbyistCovered position, as disclosed
MARY O'DEA AHEARN ALLEN —
MANUS COONEY Staff Director & Chief Counsel, Senate Judiciary Committee
JULIE PHILP LD, Rep. John Campbell; LA/Senior LA, Rep. Gil Gutknecht; LA and Scheduler, Rep. Michael Burgess; LA, Scheduler, Rep. Connie Morella; LA, Ileana Ros-Lehtinen
DAVID J URBAN Chief of Staff, Senator Arlen Specter

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.